Pictet Asset Management Holding Sa Gilead Sciences, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 3,212,654 shares of GILD stock, worth $353 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
3,212,654
Previous 4,261,363
24.61%
Holding current value
$353 Million
Previous $357 Million
16.92%
% of portfolio
0.33%
Previous 0.41%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,090Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.7 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.88 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.64 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.37 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...